GSK, Sanofi, CSL nab BARDA funding for bird flu shots – Fierce Pharma

CSL Seqirus, Sanofi and GSK have collectively secured $72 million in BARDA funding to boost the U.S. supply of bird flu vaccines.

Read More at Source.

Pumilo
Author: Pumilo